Rajeev Saggar
Technik-/Wissenschafts-/F&E-Leiter bei LIQUIDIA CORPORATION
Vermögen: 3 Mio $ am 30.04.2024
Aktive Positionen von Rajeev Saggar
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| LIQUIDIA CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 18.07.2022 | - |
Karriereverlauf von Rajeev Saggar
Ehemalige bekannte Positionen von Rajeev Saggar
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Theravance Biopharma US, Inc.
 Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Theravance Biopharma US, Inc. operates as a biopharmaceutical company. The firm serves in the areas of inflammation and immunology, drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. The company is headquartered in South San Francisco, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2021 | 01.07.2022 |
| The Banner-University Medical Center | Corporate Officer/Principal | - | - |
Ausbildung von Rajeev Saggar
| University of California, Irvine | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LIQUIDIA CORPORATION | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Theravance Biopharma US, Inc.
Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Theravance Biopharma US, Inc. operates as a biopharmaceutical company. The firm serves in the areas of inflammation and immunology, drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. The company is headquartered in South San Francisco, CA. | Commercial Services |
- Börse
- Insiders
- Rajeev Saggar
- Erfahrung
